On Tuesday, Westport Innovations Inc. (USA) (NASDAQ:WPRT)’s shares declined -7.86% to $5.51.
Westport Innovations Inc. (USA) (WPRT) stated financial results for the first quarter ended March 31, 2015 and offered an update on operations. All figures are in U.S. dollars unless otherwise stated.
The global market for natural gas vehicles demonstrated resilience with continued expansion in several markets in the first quarter of 2015 despite headwinds from volatile oil prices and economic turbulence in many of Westport’s key markets.
Westport Innovations Inc. provides low-emission engine and fuel system technologies utilizing gaseous fuels. The company’s technology and products enable light, medium, heavy-duty, and high horsepower petroleum-based fuel engines and vehicles to use primarily natural gas and alternative fuels.
Unilife Corp (NASDAQ:UNIS)’s shares dropped -7.26% to $2.94.
Unilife Corp (UNIS) declared its financial results for the quarter ended March 31, 2015 (“the third quarter of Fiscal Year 2015″, “3Q FY15″ or “Current Quarter”).
Mr. Alan Shortall, Chairman and CEO of Unilife, commented: “Our strategy to build long-term, planned partnerships with pharmaceutical and biotechnology leaders continues to gather pace. In addition to a new partnership with a major pharmaceutical company revealed in January, partnership talk aboutions also advanced favorably with a number of other companies seeking long-term access to our products and services. In parallel, we continue to broaden many existing customer relationships beyond their original scope as initial programs accelerate and additional programs get ready to commence.
Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States and internationally. The company offers Unifill, a pre-filled syringe with integrated, automatic, and user-controlled retraction; Unifill Finesse, an integrated, automatic, and user-controlled retraction with standard plunger seal and plunger rod; Unifill Select, which allows an end-user to select and attach a needle at the time of injection; Unifill Nexus that is equipped with an integrated luer adapter to provide connectivity with needleless luer access devices; and Unifill Allure, which combines universal luer connectivity with automatic, user-controlled needle retraction.
At the end of Tuesday’s trade, Continental Building Products Inc (NYSE:CBPX)‘s shares dipped -5.58% to $21.65.
Continental Building Products Inc (CBPX) declared that its largest stockholder, an associate of Lone Star Funds (the “Selling Stockholder”) intends to offer for sale in an underwritten secondary offering 4,600,000 shares of its common stock following the Company’s shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). The underwriter has a 30-day option to purchase up to an additional 690,000 shares of common stock from the Selling Stockholder. The Selling Stockholder will receive all of the proceeds from this offering. No shares are being sold by the Company. Additionally, the Company has agreed to repurchase from the Selling Stockholder in a private transaction a number of shares of common stock with an aggregate value of about $20.0 million, at a price per share equal to the per share price to be paid by the underwriter to the Selling Stockholder in the underwritten offering. The closing of the share repurchase will be contingent on the closing of the underwritten offering and is predictable to close conpresently with the closing of the offering. The closing of the underwritten offering is not contingent on the closing of the share repurchase. The last stated sale price of the Company’s common stock on May 11, 2015 was $22.93 per share. The underwritten offering is predictable to close on May 15, 2015, subject to customary closing conditions.
Continental Building Products, Inc. manufactures and sells gypsum wallboard and complementary finishing products in the eastern United States and eastern Canada. The company sells its products under the LiftLite, Mold Defense, and Weather Defense brands to gypsum wallboard distributors, buying groups, wholesalers, and mass merchants in the new residential, repair and remodel, and commercial construction markets. Continental Building Products, Inc. is headquartered in Herndon, Virginia.
Mindray Medical International Ltd (ADR) (NYSE:MR), ended its Tuesday’s trading session with -5.41% loss, and closed at $28.68.
Mindray Medical International Ltd (ADR) (MR) declared its selected unaudited financial results for the first quarter ended March 31, 2015.
Highlights for First Quarter 2015
Net revenues raised 2.9% year-over-year to $272.5 million.
China net revenues grew 5.3% year-over-year to $122.0 million, representing 44.8% of the company’s total net revenues.
International net revenues were $150.5 million, contrast to $148.9 million in the first quarter of 2014. Asia Pacific sales achieved over 25% year-over-year net revenues growth.
Reagent net revenues raised more than 30% year-over-year. Reagents led the IVD segment growth and contributed 48.3% to the IVD segment, up from 38.1% in the same period last year.
Launched three products during the quarter, counting a high-end tablet color ultrasound, and two low-end hematology analyzers.
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
